A deluge of genomic, transcriptomic, epigenomic and phenomic data presents vast opportunities to learn about the properties of living systems, but it also presents challenges.
In order to answer outstanding questions in biology and medicine, researchers need to discover meaningful and robust patterns from data. Doing so, they face of the lack of structure, the complexity and the massive size of multi-omics data sets.
Data scientists must therefore use their extensive computational know-how and harness a variety of statistical and machine learning methods in order to arrive from data to biological insight.
We're funded by the ERC StG "HYPER-INSIGHT"
In the GenomeDataLab, we strive to understand the links between mutational processes, natural selection, gene function and phenotype by means of genome analyses. In particular, we use cutting-edge computational techniques and statistical/machine learning methodologies for analyses of massive genomic, epigenomic and transcriptomic data sets.
We aim to answer important biological questions by insightful analysis of data originating from human cancers (somatic mutations, chromosomal alterations, transcriptomes), human populations (germline variants), metagenomics (including human microbiomes) and also fully sequenced microbial genomes.
We come from:
: - )
¿ you ?
GenomeDataScience group alumni:
- Marta Consuegra Martinez, postdoc
- Ingrid Tomljanović, ERASMUS+ Master Student
- Jordi Piqué Sellés, summer student (Math4life program)
- Matej Mihelčić, visiting student
- Albert Lahat, research assistant
The research interests of the Genome Data Science group are organized into four themes:
Unraveling mutational processes. Mutations are the fuel of carcinogenesis and it is imperative to learn what causes them and how they drive evolution in general, and cancer evolution in particular. We have shown that somatic mutations are unevenly distributed across the human genome due to differential activity of DNA mismatch repair (MMR), which preferentially protects gene-rich regions (Supek & Lehner 2015 Nature).
Moreover, motivated by the discoveries of APOBEC3 mutagenesis in tumors, we found another prevalent process that creates clustered mutations in many cancer types -- error-prone MMR, evident as the mutational signature of DNA polymerase eta (POLH). The histone mark H3K36me3 is an important determinant of both the standard, error-free MMR and the non-canonical, error-prone MMR (Supek & Lehner 2017 Cell).
Genomic signatures of natural selection. Most somatic mutations found in cancer cells are ‘passengers’ , with little phenotypic consequence. Detecting the few mutations among those which are ‘drivers’ is challenging, yet crucial to understand carcinogenic transformation. We have previously discovered that synonymous mutations ie. those that occur in gene coding regions but do not change the amino acid sequence, commonly drive cancer by affecting splicing patterns of oncogenes (Supek et al. 2014 Cell).
Moreover, we have learnt how the quality control pathway of nonsense-mediated mRNA decay (NMD) decides which mRNAs to degrade (Lindeboom et al. 2016 Nat Genet), and used these rules of NMD to reveal patterns of positive and negative selection on tumor suppressor genes and on essential genes.
Automated inference of gene function. Genome sequencing technologies are rapidly advancing, providing an abundance of genomes of prokaryotic and eukaryotic species, and also of populations thereof. This presents an opportunity to learn about the function of the ~1/3 of the genes for which, remarkably, a biological role is still not known.
We have devised a methodology to infer gene function from evolutionary patterns in codon biases, which serve as proxy for evolution of gene expression levels (Krisko et al. 2014 Genome Biol). We also proposed 'metagenome phyletic profiles', a compact representation of environmental DNA sequencing data -- including human microbiomes -- that can predict gene function using machine learning (Vidulin et al. 2018 Microbiome).
Genetic basis of phenotypes. Various kinds of -omics data accumulate rapidly and are increasingly organized into tidy, structured repositories. In contrast, phenomics data, while very valuable, are less often collected in a systematic manner and encoded in computable formats. This hampers the discovery of genes that underlie various phenotypes.
We have used machine learning to text-mine the scientific literature and annotate microbias species with >400 phenotypic traits (Brbic et al. 2016. Nucl Acids Res) and suggest their genetic basis, including prevalent epistasis in gene repertoires. One example are genomes of pathogenic bacteria, which tend to encode proteomes resistant to unfolding, thereby protecting the microbes from oxidative stress (Vidović et al. 2014 Cell Rep).
- Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours. A Avgustinova*, A Symeonidi [...] F Supek*, S Aznar-Benitah* (2018) Nature Cell Biology. (*corr. auth.)
Loss of activity of a H3K9 methyltransferase doesn't alte the global landscape of mutations in chemically induced tumors // DNA replication time and H3K36me3 histone mark, not chromatin accesibility, are determinants of mutation rates // H3K9me2/3-depleted tumors are genomically instable, and after a prolonged latency, very agressive
- The evolutionary signal in metagenome phyletic profiles predicts many gene functions. V Vidulin, T Smuc, S Dzeroski, F Supek (2018) Microbiome.
An increasing availability of microbiome DNA sequencing data provides an opportunity to infer gene function in a systematic manner // Metagenome phyletic profiles (MPPs) can accurately predict 826 Gene Ontology functional categories // MPPs derived from diverse environments infer distinct, non-overlapping sets of gene functions
- Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits. S Park, F Supek, B Lehner (2018) Nature Communications.
A statistical method, ALFRED, tests Knudson’s two-hit hypothesis to systematically identify inherited cancer predisposing genes // We identify novel genes, such as the chromatin modifier NSD1, which cause cancer through germline variants and somatic loss-of-heterozygosity // 1 in 50 tumors is associated with novel ALFRED genes
- Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes. F Supek, B Lehner (2017) Cell.
Mutation clusters in cancer genomes provide fingerprints of mutagenic mechanisms // Error-free mismatch repair lowers the mutation rate in H3K36me3-marked active genes // Error-prone repair using POLH also targets H3K36me3, contributing driver mutations // UV and alcohol increase error-prone repair, targeting mutations toward active genes.
- The rules and impact of nonsense-mediated mRNA decay in human cancers. RGH Lindeboom, F Supek*, B Lehner* (2016) Nature Genetics. (*corr. auth.)
Matched exome and transcriptome data can systematically elucidate the rules of NMD targeting in human tumors, explaining ¾ of the variance in NMD efficiency. Applying our NMD model identifies signatures of positive and negative selection on nonsense mutations in human tumors and provides a classification for tumor-suppressor genes.
"The best thing about being a statistician is that you get to play in everyone's backyard." -- John Tukey.
- Differential DNA mismatch repair underlies mutation rate variation across the human genome. F Supek, B Lehner (2015) Nature.
Somatic mutation rates exhibit tissue-specificity coupled to regional changes in DNA replication timing and gene expression. A temporal deconvolution of mutational signatures in microsatellite-instable tumors of the colon, stomach and uterus demonstrates that post-replicative MMR is the cause of the megabase-scale mutation rate variability in the human genome.
- Synonymous mutations frequently act as driver mutations in human cancers. F Supek, B Miñana, J Valcárcel, T Gabaldón, B Lehner (2014) Cell.
Enrichments of somatic mutations indicate that ~1 in 5 synonymous mutations in oncogenes are cancer drivers. Involvement in known exonic splicing motifs and association to RNA-Seq data implicates many causal synonymous mutations to altered splicing. The 3’ UTRs of dosage-sensitive oncogenes also harbour causal mutations.
- Inferring gene function from evolutionary change in signatures of translation efficiency. A Krisko, T Copic, T Gabaldón, B Lehner, F Supek (2014) Genome Biology.
The changes in codon adaptation in orthologous gene families can systematically predict function of many genes by employing machine learning to rule out confounding variables. We have experimentally validated novel roles in adaptation to environmental stressors (oxygen, heat, salinity) for tens of E. coli genes.
- The landscape of microbial phenotypic traits and associated genes. M Brbić, M Piškorec, V Vidulin, A Kriško, T Šmuc, F Supek. (2016) Nucl Acids Res.
We have systematically annotated >3,000 prokaryotic taxa with >400 phenotypes, while drawing on comparative genomics and text mining techniques. This reveals thousands of gene families causally involved in various microbial traits, as well as pervasive epistasis that has shaped gene repertoires of these organisms.
- The Code of Silence: Widespread Associations Between Synonymous Codon Biases and Gene Function. F Supek. (2016) J Mol Evol. (review)
Comparative analyses of genomes, from bacteria across fungi to humans and human tumors have revealed many links between genes' biological roles and the accrual of synonymous mutations. The evolutionary trace of codon bias patterns across homologous genes may be examined to learn about a gene’s relevance to various phenotypes, or, more generally, its function in the cell.
We gratefully acknowledge our funders:
European Research Council
The Spanish Ministry of Economy and Competitiveness, via MINECO grant BFU2017-89833-P "RegioMut".
Core funding and a student fellowship are funded by the Severo Ochoa excellence award to the IRB Barcelona.
Fran Supek is funded by the ICREA Research Professor program.
"Prediction is very difficult, especially about the future. " -- Niels Bohr.